Trinity's Next Gen Launch Report Shows Pharmaceutical Launches Deliver Strong Performance in the Face of Uncertainty

Summary

Trinity released research showing 51% of U.S. drug launches exceeded Wall Street revenue expectations in 2025, with oncology products performing particularly well despite market uncertainty.